Montreal Heart Institute Colcorona Study receives grant from the COVID-19 Therapeutics Accelerator via the Bill & Melinda Gates Foundation to investigate cheap, readily available drug

NEXT STORY
Plus Therapeutics Announces Patient-Focused Presentation Supporting Brain Tumor Awareness Month
PREV STORY
Phathom Pharmaceuticals Reports First Quarter 2020 Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Montreal Heart Institute Colcorona Study receives grant from the COVID-19 Therapeutics Accelerator via the Bill & Melinda Gates Foundation to investigate cheap, readily available drug

NEXT STORY
Plus Therapeutics Announces Patient-Focused Presentation Supporting Brain Tumor Awareness Month
PREV STORY
Phathom Pharmaceuticals Reports First Quarter 2020 Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Targovax to present at upcoming conferences

Oslo, Norway, 6 March 2017: Targovax ASA ("Targovax" or "the Company"; OSE: TRVX), a ...

author_avatar
NASDAQ Market News

Trillium Announces Proposed Public Offering of Common Shares

author_avatar
NASDAQ Market News

LAG-3Ig (IMP321) Demonstrates Positive Safety and Efficacy Qualities in Breast Cancer Clinical Trial

SYDNEY, Australia, June 04, 2017 (GLOBE NEWSWIRE) -- Breast cancer clinical trial demonstrates LAG-3Ig ...

author_avatar
NASDAQ Market News